Aura Biosciences director granted RSUs, stock options
Aura Biosciences director Sapna Srivastava received new equity awards in the form of stock and options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aura Biosciences director Sapna Srivastava received new equity awards in the form of stock and options. She was granted 15,000 shares of Common Stock through a restricted stock unit (RSU) award and 30,000 stock options with an exercise price of $6.21 per share.
The RSUs and options each vest in full on the earlier of June 11, 2027 or the company’s next annual stockholder meeting, subject to her continued service. After the RSU grant, her direct Common Stock holdings total 38,500 shares, and she holds 30,000 options to buy additional shares.
Insider Trade Summary
Grant/Award: 45,000 shares
Grant/Award
2 txns
Insider
Srivastava Sapna
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 30,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 15,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 30,000 contracts (Direct);
Common Stock — 38,500 shares (Direct)
Footnotes (2)
- F1. These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
- F2. This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
Key Figures
RSU grant: 15,000 shares
Stock options granted: 30,000 options
Option exercise price: $6.21 per share
+3 more
6 metrics
RSU grant
15,000 shares
Restricted stock units granted to director on June 11, 2026
Stock options granted
30,000 options
Options on Common Stock granted on June 11, 2026
Option exercise price
$6.21 per share
Strike price for 30,000 stock options
Shares after RSU grant
38,500 shares
Total direct Common Stock held following RSU award
Option expiration date
June 11, 2036
Expiration of 30,000 stock options
Vesting date trigger
Earlier of June 11, 2027 or next annual meeting
Vesting condition for RSUs and options
Key Terms
restricted stock unit, RSU, 2021 Stock Option and Incentive Plan, stock option, +1 more
5 terms
restricted stock unit financial
"These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
RSU financial
"Each RSU represents the right to receive one share of the Issuer's Common Stock."
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
2021 Stock Option and Incentive Plan financial
"These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan."
stock option financial
"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Common Stock financial
"Each RSU represents the right to receive one share of the Issuer's Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Aura Biosciences (AURA) director Sapna Srivastava report on this Form 4?
She reported receiving equity compensation: 15,000 restricted stock units and 30,000 stock options. Both awards relate to Aura Biosciences Common Stock and were granted without a cash purchase, reflecting routine director compensation rather than an open-market stock transaction.
What are the terms of the 15,000 RSUs granted to Sapna Srivastava at Aura Biosciences (AURA)?
The 15,000 RSUs each represent one share of Common Stock and were granted under Aura’s 2021 Stock Option and Incentive Plan. They vest in full on the earlier of June 11, 2027 or the next annual stockholder meeting, assuming her continued service.
What are the key details of the 30,000 stock options granted to Sapna Srivastava at Aura Biosciences (AURA)?
She received 30,000 stock options to purchase Common Stock at an exercise price of $6.21 per share. These options vest in full on the earlier of June 11, 2027 or the next annual stockholder meeting and expire on June 11, 2036.
Were Sapna Srivastava’s Aura Biosciences (AURA) Form 4 transactions open-market buys or sales?
No. The filing shows grant or award acquisitions coded as “A,” not open-market purchases or sales. She received RSUs and stock options as compensation, with no reported market trading activity in the company’s shares in this Form 4.
Under which plan were the Aura Biosciences (AURA) RSUs granted to Sapna Srivastava?
The 15,000 RSUs were granted under Aura Biosciences’ 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of Common Stock, subject to the specified vesting conditions and her continued service with the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates